Cargando…
Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
Introduction: Cell-free DNA (cfDNA) analysis offers a non-invasive method to identify sensitising and resistance mutations in advanced Non-Small Cell Lung Cancer (NSCLC) patients. Next-generation sequencing (NGS) of circulating free DNA (cfDNA) is a valuable tool for mutations detection and disease′...
Autores principales: | Fernandes, Maria Gabriela O., Sousa, Catarina, Pereira Reis, Joana, Cruz-Martins, Natália, Souto Moura, Conceição, Guimarães, Susana, Justino, Ana, Pina, Maria João, Magalhães, Adriana, Queiroga, Henrique, Marques, José Agostinho, Machado, José Carlos, Costa, José Luís, Hespanhol, Venceslau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394732/ https://www.ncbi.nlm.nih.gov/pubmed/34440680 http://dx.doi.org/10.3390/cells10081912 |
Ejemplares similares
-
Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021) -
Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2019) -
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021) -
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
por: Freitas, Cláudia, et al.
Publicado: (2021) -
Spontaneous regression of a pulmonary adenocarcinoma after core needle biopsy
por: Marques, Cristiana, et al.
Publicado: (2017)